MISSISSAUGA, Ontario, September 16, 2025--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced ...
April 27, 2012 (Phoenix, Arizona) — The rate of inappropriately placed central venous catheters (CVCs) substantially declines when residents and emergency department (ED) technicians are trained to ...
The routine use of alcohol-impregnated disinfection devices on all central-line access ports effectively and significantly reduces central-line-associated bloodstream infections (CLABSIs), new ...
Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding successful ways to stop germs ...
The management of many medical and surgical conditions often involves long-term infusion of intravenous fluids, broad-spectrum antibiotics, chemotherapeutic agents for cancer, critical care therapies, ...
Totally implantable vascular access device (TIVAD)-related complications interfere in the anticancer treatment and increase medical expenses. We examined whether the implantation side of central line ...
Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results